Market Access
Market access for medical devices in Europe: England, France, Germany, Italy and Spain (Report #1)
Market Access Landscape for Health Apps in Europe (Report #24)
Reimbursement Pathways for Companion Diagnostic (CDx) Tests in Europe (Report #21)
Case Study: Market Access for Mechanical Thrombectomy in England (Report #14)
Case study: Market Access Pathway for TAVI in France (Report #22)
Case study: Market Access for Preeclampsia Predictive Tests in Germany and Norway (Report #23)
Challenges of HTA and Reimbursement Submissions for Medical Devices (Report #18)
Evidence Requirements
Evidence Gap Analysis for Medical Technologies in Europe – a Practical Example (Report #3)
Evidence requirements for LPPR List process in France, part 1 (Report #5)
Evidence requirements for LPPR List process in France, part 2 (Report #6)
Evidence requirements for reimbursement of diagnostic (non-IVD) methods in France (Report #7)
Evidence requirements for coverage of medical technologies in the Netherlands (Report #9)
Evidence requirements for medical devices in the regional HTA program in Italy (Report #11)
Evidence requirements for Med Tech Early Value Assessment at NICE in the United Kingdom (Report #4)
Value Dossiers for Medical Technologies: What, When and How? (Report #12)
Challenges and Proposed Solutions in SLR for Medical Devices (Report #15)
Best Reporting Checklists for Studies of Medical Devices (Report #20)